JP2025516703A5 - - Google Patents
Info
- Publication number
- JP2025516703A5 JP2025516703A5 JP2024567520A JP2024567520A JP2025516703A5 JP 2025516703 A5 JP2025516703 A5 JP 2025516703A5 JP 2024567520 A JP2024567520 A JP 2024567520A JP 2024567520 A JP2024567520 A JP 2024567520A JP 2025516703 A5 JP2025516703 A5 JP 2025516703A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- amino acid
- bispecific polypeptide
- polypeptide according
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263342052P | 2022-05-13 | 2022-05-13 | |
| US63/342,052 | 2022-05-13 | ||
| PCT/US2023/067028 WO2023220761A2 (en) | 2022-05-13 | 2023-05-15 | Biotin orthogonal streptavidin system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025516703A JP2025516703A (ja) | 2025-05-30 |
| JP2025516703A5 true JP2025516703A5 (cg-RX-API-DMAC7.html) | 2026-05-20 |
Family
ID=88731171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024567520A Pending JP2025516703A (ja) | 2022-05-13 | 2023-05-15 | ビオチン直交ストレプトアビジン系 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250304705A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4522281A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025516703A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023220761A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4522281A2 (en) * | 2022-05-13 | 2025-03-19 | University of Utah Research Foundation | Biotin orthogonal streptavidin system |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6451995B1 (en) * | 1996-03-20 | 2002-09-17 | Sloan-Kettering Institute For Cancer Research | Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods |
| EP2721072A4 (en) * | 2011-06-20 | 2015-03-04 | Akrivis Technologies Llc | REAGENTS AND METHODS FOR BINDING TARGET MOLECULES BASED ON BISPECIFIC ANTIBODIES |
| WO2019190954A1 (en) * | 2018-03-26 | 2019-10-03 | Rootpath Genomics, Inc. | Target binding moiety compositions and methods of use |
| US12643944B2 (en) * | 2019-11-12 | 2026-06-02 | Iprogen Biotech Inc. | Antibody-payload conjugates with enhanced delivery domain and uses thereof |
| WO2021226290A1 (en) * | 2020-05-05 | 2021-11-11 | 10X Genomics, Inc. | Methods for identification of antigen-binding molecules |
| WO2022080486A1 (ja) * | 2020-10-16 | 2022-04-21 | シスメックス株式会社 | ポリペプチド、多量体、固相、被検物質の測定方法および試薬キット |
| EP4522281A2 (en) * | 2022-05-13 | 2025-03-19 | University of Utah Research Foundation | Biotin orthogonal streptavidin system |
-
2023
- 2023-05-15 EP EP23804561.1A patent/EP4522281A2/en active Pending
- 2023-05-15 US US18/863,298 patent/US20250304705A1/en active Pending
- 2023-05-15 JP JP2024567520A patent/JP2025516703A/ja active Pending
- 2023-05-15 WO PCT/US2023/067028 patent/WO2023220761A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7685095B2 (ja) | 多重特異性抗体とその作製及び使用方法 | |
| US11878058B2 (en) | Antigen binding proteins that bind PD-L1 | |
| US11242391B2 (en) | Antigen binding proteins that bind PD-1 | |
| CN107405397B (zh) | 抗tim-3抗体 | |
| US11787863B2 (en) | Multi-specific antibodies and methods of making and using thereof | |
| JP7356970B2 (ja) | 多重特異性抗体とその作製及び使用方法 | |
| JP6866294B2 (ja) | 抗pd−l1抗体 | |
| CN107530420A (zh) | 抗tim‑3抗体 | |
| CN107148281A (zh) | 结合cxcr5的抗原结合蛋白 | |
| AU2020271467B2 (en) | Antibodies against programmed death-ligand 1 and uses thereof | |
| JPH0246297A (ja) | モノクローナル抗体、抗体産生ハイブリドーマおよび抗体の製造法 | |
| US20240279333A1 (en) | Multi-specific antibodies and methods of making and using thereof | |
| CA3147887A1 (en) | Composition and methods of targeting the pre-b cell receptor for the treatment of leukemias and lymphomas | |
| HK40018991A (en) | Multi-specific antibodies and methods of making and using thereof | |
| HK40019010A (en) | Multi-specific antibodies and methods of making and using thereof |